Literature DB >> 21103622

Ki-67 expression in gastric cancer. Results from a prospective study with long-term follow-up.

Daniela Lazăr1, Sorina Tăban, I Sporea, Alis Dema, Mărioara Cornianu, Elena Lazăr, A Goldiş, Corina Vernic.   

Abstract

BACKGROUND: The characteristics of the cellular kinetic reflect the aggressiveness of the tumors and even their prognosis, many studies proving the correlation between the increased proliferation activity and a poor prognosis in a variety of neoplasms. AIM: The analysis of immunohistochemical expression of the Ki-67 antigen using the monoclonal antibody MIB1 in 61 patients with gastric cancer, the correlation with clinicopathological factors and the prognosis of the patients.
MATERIAL AND METHODS: We used the primary MIB1 antibody pre-diluted, using the LSAB technique, DAB visualization. The quantification of the reaction was performed by appreciating the marking index Ki-67 (MI Ki-67). Although all the lesions were positive, we noticed a marked intratumoral heterogeneity regarding the distribution of the Ki-67 score. The tumor cells were considered Ki-67 positive in the presence of brown nuclear staining of granular or diffuse type. The tumor invasion front has shown the most numerous Ki-67 positive cells.
RESULTS: In the gastric carcinomas, we remarked various Ki-67 scores. For a proper grouping of the results, we classified gastric carcinomas into two categories: carcinomas with high MI Ki-67 (≥45%) and carcinomas with low MI Ki-67 (≤45%). We noticed an increased frequency of high MI Ki-67 carcinomas in elderly patients (p=0.03) and also in the tumors developed at cardia level and those extended in the entire stomach in the moment of diagnosis (p<0.001). The histological forms associated to high Ki-67 values are represented by the anaplastic carcinoma (100% of cases) and papillary adenocarcinoma (60% of cases).We observed a close correlation between the degree of tumor differentiation and the Ki-67 score (p<0.001). The results of our study do not reveal any correlation between the Lauren's Classification of gastric carcinomas, the lymphovascular invasion, the depth of tumor invasion, the TNM stage and the Ki-67 score (p>0.05).
CONCLUSIONS: In our study, immunohistochemical assessment of the tumor proliferation does not represent a prognostic factor, but seems to be useful in identifying of a group of patients with aggressive tumors, needing adjuvant postoperatory chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21103622

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  13 in total

1.  Increased Proliferative Activity Accompanies the Local Inflammatory Response of Gastric Mucosa After Intragastric Balloon Insertion.

Authors:  Ehab Atef; Khaled Refaat Zalata; Hoda Atef; Ahmed A M Abdel-Hamid
Journal:  Dig Dis Sci       Date:  2016-10-14       Impact factor: 3.199

2.  Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.

Authors:  Ming Yang; Xiaoxia Wang; Qi Zhao; Tianbo Liu; Guodong Yao; Wenhao Chen; Zhiwei Li; Xiaoyi Huang; Yanqiao Zhang
Journal:  Tumour Biol       Date:  2014-05-02

3.  High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.

Authors:  Hua-Rong Tang; Xian-Qin Luo; Gang Xu; Yan Wang; Zhi-Jun Feng; Hui Xu; Ya-Wei Shi; Qin Zhang; Li-Guang Wu; Chun-Quan Xue; Cheng-Wei Wang; Chao-Yang Wu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma.

Authors:  Krishna Pillai; Mohammad H Pourgholami; Terence C Chua; David L Morris
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

5.  Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas.

Authors:  Li-Jun Xiao; Shuang Zhao; En-Hong Zhao; Xin Zheng; Wen-Feng Gou; Yasuo Takano; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2013-08-19       Impact factor: 2.967

Review 6.  Clinicopathologic significance and prognostic value of Ki-67 expression in patients with gastric cancer: a meta-analysis.

Authors:  Guanying Luo; Yunzhao Hu; Zhiqiao Zhang; Peng Wang; Zhaowen Luo; Jinxin Lin; Canchang Cheng; You Yang
Journal:  Oncotarget       Date:  2017-07-25

7.  Ki67--An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity.

Authors:  Christine Böger; Hans-Michael Behrens; Christoph Röcken
Journal:  J Surg Oncol       Date:  2015-12-28       Impact factor: 3.454

8.  Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients.

Authors:  Young-Woo Kim; Bang Wool Eom; Myeong-Cherl Kook; Han-Seong Kim; Mi-Kyung Kim; Hai-Li Hwang; Vishal Chandra; Shiv Poojan; Yura Song; Jae-Soo Koh; Chang-Dae Bae; Jungsil Ro; Kyeong-Man Hong
Journal:  Exp Mol Med       Date:  2015-11-06       Impact factor: 8.718

9.  Tracking the tumor invasion front using long-term fluidic tumoroid culture.

Authors:  Koh Meng Aw Yong; Zida Li; Sofia D Merajver; Jianping Fu
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

10.  Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma.

Authors:  Ayesha Ahmed; Dalal M Al-Tamimi
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.